AIU Chair David Howman (pictured above) presented the AIU’s testing plan for Budapest 23 to the World Athletics’ Congress on Thursday.
The AIU has been closely monitoring national testing programmes in the lead-up to Budapest, in accordance with Rule 15 of the World Athletics Anti-Doping Rules, and has observed that the level of testing of elite athletes has generally increased compared with last year, thanks to the joint efforts of the AIU and National Federations, supported by their National Anti-Doping Organisation (NADO). Due to exceptional circumstances arising from the war in Ukraine, the AIU Board has exempted 12 Ukrainian athletes from the strict eligibility requirement under Rule 15 to have at least three out-of-competition tests in the ten months prior to the Championships.
Another key component of the AIU’s mission at Budapest 23 is the continuation of a pilot study, initiated last year in collaboration with the United States Anti-Doping Agency (USADA), which has been exploring a new and less invasive method for collecting blood samples from athletes for anti-doping profiling purposes. Athletes selected for doping control in Budapest will be asked to contribute to the study by providing an additional sample using the new device. The results will be compared with the routine samples.
“The AIU is constantly looking to innovate and upgrade our technology, and this is a major step in advancing our blood-collection protocols. There were some very promising results trialling the new device at previous events, including this year’s Boston Marathon,” explained Howman.
As for every World Championships, doping control samples collected in Budapest will be transferred to a dedicated long-term storage facility, after the initial analyses have been performed, with the view to re-analyse them in the future, using the latest available detection analyses or methods.